We have accomplished the straightforward preparation of hitherto unknown cholinesterases inhibitors based on the use of the iminosugar 1-DNJ as the key pharmacophore for struggling with the low levels of the neurotransmitter acetylcholine in Alzheimer’s disease. This evidence concerns the gene BCHE and Alzheimer disease.